While the upside is appealing, penny stocks carry some risks.
December S&P 500 futures (ESZ22) are trending up +0.23% this morning after three major US benchmark indices ended Monday roughly down as market participants remained cautious after reports suggested China...
Announced FDA acceptance of FUROSCIX® New Drug Application and Prescription Drug User-Fee Act target action date of October 8, 2022 Continued to advance...
BURLINGTON, Mass., July 13, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and...
Study results favor FUROSCIX® versus “treatment as usual” in composite primary endpoint and all secondary endpoints FUROSCIX demonstrated an acceptable...
Virtual event scheduled for Wednesday, July 13 at 10:00 AM EDT...
Oral and moderated poster presentations of FREEDOM-HF study to be presented...